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Abstract
Background: The theory of traditional Chinese medicine (TCM) constitution involves genetic characteristics,
psychological factors, organ functions, and many other aspects. Studies have shown that TCM constitution is
associated with HLA polymorphisms and has a genetic basis. A large number of Chinese studies have suggested that
the clinical evolution of breast cancer may differ among patients with different TCM constitutions. In addition,
patients with breast cancer and different TCM constitutions may have different degrees of myelosuppression after
chemotherapy. Some studies have revealed that some constitutions may become predictive factors for death and
morbidity of some diseases. The study was to investigate the risk factors among TCM constitutions for chemotherapy-
induced nausea and vomiting (CINV) in patients with primary breast cancer undergoing chemotherapy.
Methods: From September 2008 to January 2014, 612 patients who underwent surgery and chemotherapy for breast
cancer in three hospitals in Xi’an, Shanxi province, underwent TCM constitution assessment using the Nine Basic
Constitutions in Chinese Medicine Questionnaire before chemotherapy. CINV was monitored during treatments.
Patients were asked to complete the Functional Living Index-Emesis (FLIE) questionnaire. The most severe CINV grade
during chemotherapy was recorded according to the WHO standard. The relationships between TCM constitutions,
CINV, and clinical and pathological characteristics of the cancers were assessed.
Results: There were no differences in the incidence of CINV among breast cancer patients receiving different
chemotherapy regimens, and among patients with different TCM constitutions. The wetness-heat score was an
independent risk factor for severe CINV (grade III-IV) (OR = 1.012, 95 % CI: 1.007–1.021, P < 0.001). In-depth analyses of
the wetness-heat constitution showed that bitter taste/smelly mouth was an independent risk factor for severe CINV
(OR = 1.209, 95 % CI: 1.035–1.412, P = 0.017), as well as progesterone receptor-positive cancer (OR = 1.429, 95 % CI:
1.030–1.981, P = 0.032). Vomiting history was a protective factor against CINV (OR = 0.548, 95 % CI: 0.353–0.849, P = 0.007).
Conclusion: Risk of grade III-IV nausea and vomiting was higher in breast cancer patients with TCM constitution of
wetness-heat, especially bitter taste or smelly mouth.
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Background
Breast cancer is the most common cancer in women [1].
Endocrine therapy and targeted therapy are becoming
increasingly important in the treatment of breast cancer
[2], and gene expression profiles are being increasingly
used to guide the selection of therapies. However,
chemotherapy still plays an important role in breast
cancer treatment [2] and its numerous side effects still
require specific care. Chemotherapy-induced nausea and
vomiting (CINV) is still the most common and one of
the most distressing adverse reactions of chemotherapy.
Since female gender itself is an independent risk factor
for CINV [3], CINV in women with breast cancer might
be even more common and severe compared with other
cancers. Indeed, 77.3 % of patients with breast cancer
experience nausea and 50 % experience vomiting [4],
severely affecting the quality of life and requiring anti-
emetic treatments [5].
Many risk factors are associated with CINV, among
which the emetogenic force of the chemotherapy regi-
men is the most important factor for severe CINV.
However, CINV severity may significantly differ between
individuals even if the same chemotherapy regimen is
used, and risk factors such as ethnic group, psycho-
logical factors, mental preparation for nausea and vomit-
ing, organ status, young age, female gender, prior CINV
history, history of morning and motion sickness, and
low alcohol use are associated with CINV [6–9]. These
studies revealed that for patients receiving anthracy-
clines, the risk of severe CINV in Asian patients was sig-
nificantly higher than in non-Asian patients [6].
The theory of traditional Chinese medicine (TCM)
constitution involves genetic characteristics, psychological
factors, organ functions, and many other aspects [10].
Constitution refers to congenital and acquired inherent
characteristics that are comprehensive and relatively stable
in morphological structures, physiological functions, and
psychological status in the process of human life. Studies
have shown that TCM constitution is associated with
HLA polymorphisms [11] and has a genetic basis [12].
Therefore, TCM constitutions determine the individual’s
specificity [13], which often determines his/her suscepti-
bility to certain pathogenic factors as well as different
responses to drugs [9]. According to the theory of TCM
constitution, there are nine kinds of constitutions includ-
ing one normal constitution (gentleness), and eight patho-
logical constitutions (yang-deficiency, yin-deficiency, qi-
deficiency, phlegm-wetness, wetness-heat, qi-depression,
blood-stasis, and special diathesis).
A large number of Chinese studies have suggested that
the characteristics and clinical evolution of breast cancer
may differ in patients with different TCM constitutions
[14–16], and TCM constitution influences the incidence,
development, and prognosis of breast cancer [14]. In
addition, patients with breast cancer and different TCM
constitutions may have different degrees of myelosup-
pression after chemotherapy [17]. Some studies have re-
vealed that some constitutions may become predictive
factors for death and morbidity of some diseases [18].
Therefore, the present study aimed to investigate the
association between TCM constitutional types and
CINV in patients with breast cancer. Results could help
identifying risk factors for severe CINV and help clini-
cians to manage CINV more effectively in these patients.
Methods
Patients
Patients who were postoperatively diagnosed with breast
cancer upon histological examination of the surgical spe-
cimen at The First Hospital of XI’an Jiaotong University,
the Shaanxi General Hospital of Chinese Armed Police
Force (CAPF), and the Shaanxi Province Hospital of
traditional Chinese medicine between September 2008
and January 2014 were screened for eligibility (n = 1745).
Inclusion criteria were: 1) histologically confirmed breast
cancer; 2) underwent surgery; and 3) Karnofsky per-
formance status (KPS) score ≥60. Exclusion criteria were:
1) received radiotherapy and/or chemotherapy within one
year before surgery; 2) severe infection, severe dyscrasia,
severe primary diseases (such as cardiovascular disease,
cerebrovascular disease, or disease of the liver, kidney,
hematopoietic system, endocrine system, mental disease,
or sarcopenia); 3) any diagnosis of gastrointestinal disease;
4) nausea or vomiting before chemotherapy; or 5) taking
drugs that might affect the incidence of nausea and vomit-
ing (such as antiviral drugs, antibiotics, or morphine). Pa-
tients were allowed to withdraw from chemotherapy for
medical reasons or based on patients’ will, but those who
experienced CINV before withdrawal were included in the
analyses. Eventually, 619 patients were included in the
study, and 612 were analyzed (four patients were lost to
follow-up, and three had incomplete dataset) (Fig. 1).
Ethics, consent and permissions
The study was involved human participants and ap-
proved by the ethics committee of the First Affiliated
Hospital of Xi’an Jiaotong University and then was sub-
sequently passed by the ethics committee of the other
two participating hospitals.
Data collection
Before chemotherapy, the general characteristics of the
patients were collected including age, education level,
and family history of breast cancer. History of nausea
and vomiting was defined as any persistent event that
affected their lives and/or required medical interven-
tions. Before chemotherapy, the therapy-related clinical
characteristics of the patients were collected including
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TNM staging, pathological type of the tumor, KPS score,
chemotherapy regimen, estrogen receptors (ER) status,
progesterone receptor (PR) status, human epidermal
growth factor receptor-2 (HER2) status, p53 protein ex-
pression, p21 protein expression, and PCNA expression.
To determine the expression status of different proteins,
positive cells were counted in 10 random and non-
overlapping fields at high magnification and each field
had to have at least 100 tumor cells. Positive ER and PR
statuses were based on the ≥1 % threshold of the ASCO-
CAP [19]. HER2, p53, p21, and PCNA positivity was
based on a >10 % threshold.
Assessment and treatment of nausea and vomiting
Three to five days before chemotherapy, the patients
were instructed by specialized physicians how to use the
visual analogue scale (VAS) for nausea [20]. The VAS
was a 100-mm ruler divided into 10 intervals from left
to right, where the left end was 0 (no nausea) and the
right end was 10 (the most imaginable violent nausea).
After each course of chemotherapy was started, the pa-
tients were required to keep a 120-h log of the occur-
rence of nausea and vomiting, which required to record
any kind of nausea and/or vomiting including frequency,
symptoms, and measures taken. The logs were examined
daily by specialized physicians. Patients were asked to
complete the FLIE questionnaire by applying the VAS
for nausea severity on the 6th day after chemotherapy. A
FLIE total score >108 points meant that the nausea and
vomiting were tolerable and had no effect on the daily
life [21]. If the patients were not hospitalized on the 6th
day after chemotherapy, they were followed up by phone
and were asked to complete the log, hereby ensuring the
validity and reliability of data collection. The logs were
collected at each cycle of chemotherapy.
During and after chemotherapy, CINV was graded for
each patient according to the WHO standard, and the
highest grade of each patient was taken for statistical
analyses. Grade 0: no nausea and vomiting; Grade I: only
nausea; Grade II: temporary and tolerable vomiting;
Grade III: intolerable vomiting that required treatments;
and Grade IV: uncontrollable vomiting. Grades 0-II were
classified as mild nausea and vomiting, while Grades III-
IV were classified as severe nausea and vomiting.
All patients received prophylactic antiemetics, but were
not receiving preventive non-pharmacological interven-
tions such as behavioral therapy, acupuncture, and TCM
therapy. The beginning of each chemotherapy cycle was
considered as “day 1” for conducting standard antiemetic
prevention: ondansetron 8 mg IV on day 1 (15 min before,
and 4 and 8 h after chemotherapy) and on days 2–5; and
dexamethasone injection 10 mg IV on days 1–3. Patients
with anticipatory CINV received lorazepam.
Patients with grade ≥ III nausea and vomiting immedi-
ately received antiemetic drugs or participated in non-
pharmacological interventions. Before each cycle of
chemotherapy, routine blood tests, liver function, kidney
function, and ECG were checked, and chemotherapy-
related side effects were assessed according to the WHO
acute and subacute toxicity grading of anticancer drugs.
Patients with side effects received symptomatic treatment,
and the continuation of chemotherapy was determined by
the attending physician according to the severity of the side
effects.
Chemotherapy regimens
Chemotherapy regimens were selected according to the
NCCN guidelines (http://www.nccn.org/) issued from
2008 to 2013 and according to the financial means of
the patients. Each patient received 2–6 cycles of che-
motherapy, with a median of 4 cycles. Ultimately, pa-
tients receiving any one of the following eight regimens
were enrolled: CAF (cyclophosphamide, adriamycin, and
fluorouracil), 28-day cycles; CEF (cyclophosphamide,
epirubicin, and fluorouracil), 21-day cycles; AC (adria-
mycin and cyclophosphamide), 21-day cycles; EC (epiru-
bicin and fluorouracil), 21-day cycles; TAC (docetaxel,
Fig. 1 Patients’ flowchart
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adriamycin, and cyclophosphamide), 21-day cycles; TEC
(docetaxel, epirubicin, and cyclophosphamide), 21-day
cycles; TA (pacilitaxel and adriamycin), 21-day cycles;
and TE (docetaxel and epirubicin), 21-day cycles.
TCM constitutional types
Before chemotherapy, the patients’ TCM constitutional
types were classified and quantified according to the Nine
Basic Constitutions Classification and Criteria in Chinese
Medicine [12, 22] issued by the China Association of
Chinese Medicine. The Constitution in Chinese Medicine
Questionnaire includes 60 items (please see the Appendix),
in which items of nine subscales (each subscale consists of
7–8 items) are interspersed irregularly. For each item, an
appropriate answer was selected from a Likert scale (“no”,
“occasionally”, “sometimes”, “often”, and “always”, scored
1–5). For each subscale, the original score was first calcu-
lated (original score = sum of the scores for each item) and
converted into the derived score [(actual score-the possible
lowest score of the subscale)/(possible highest score- pos-
sible lowest score)×100]. The derived score of each
subscale ranged 0–100 points. Ultimately, the TCM consti-
tution was diagnosed. Gentle constitution referred to the
patients with derived scores of the eight deviation constitu-
tions being <30 points, and the derived score of the gentle-
ness constitution being ≥60 points. Deviation constitutions
were diagnosed if the score of any constitution subscale
was ≥40 points. Patients with a derived score of a deviation
constitution between 30 and 40 points were referred to as
“tendency of deviation constitution”. Patients with two or
more constitutional types were recorded twice or more.
Patients with a “tendency of deviation constitution” were
excluded from the statistical analysis because they were
not diagnosed with the deviation constitution. Patients
diagnosed with “special diathesis” were excluded from the
analysis of risk factors of CINV due to the very small
number of cases (n = 4).
Statistical analysis
Statistical analyses were performed using SPSS 16.0 (IBM,
Armonk, NY, USA). Continuous data are expressed as
mean ± standard deviation and were compared using
ANOVA with the Tukey’s post hoc test. Categorical data
are expressed as frequencies and were analyzed using the
Pearson chi-square test. Variables associated with CINV at
P < 0.10 in univariate analyses were included in the multi-
variate model. Because of the small number of patients in
some constitutions, the relationship between the nine
TCM constitutions and CINV was analyzed using logistic
regression based on the actual scores of each constitution
instead of the diagnoses themselves. Two-sided P-values
<0.05 were considered statistically significant.
Results
Characteristics of the patients
Figure 1 presents the patients’ flowchart. Table 1 pre-
sents the characteristics of the patients. Among all pa-
tients, 18.6 % had a history of nausea/vomiting. CINV
severity was grade 0 in 7.8 % of the patients, grade I-II
in 47.5 %, and grade III-IV in 44.7 %. The chemotherapy
regimens are presented in Table 2. There were no sig-
nificant differences in the incidence of CINV between
the regimens (P = 0.342).
TCM constitutional types
A total of 510 constitution cases were analyzed, which was
smaller than the total number of patients because it was
impossible to achieve a TCM constitutional diagnosis in
some patients. Among these 510 cases, there were 77 cases
of gentleness constitution (15.0 %), 146 of qi-depression
constitution (28.6 %), 83 of qi-deficiency constitution
(16.3 %), 66 of yang-deficiency constitution (12.9 %), 58 of
yin-deficiency constitution (11.4 %), 34 of blood-stasis con-
stitution (6.7 %), 22 cases of Wetness-heat constitution
(4.3 %), 20 cases of phlegm-wetness constitution (3.9 %),
and four of special diathesis constitution (0.8 %) (Table 3).
Table 1 Characteristics of the patients
Index N (%)
Age (year) <35 12 (2.0)
35–60 544 (88.8)
>61 56 (9.2)
Education level Junior middle school or above 250 (40.9)




History of vomitinga Yes 114 (18.6)




Pathological type Infiltrating ductal carcinoma 294 (48.0)




KPS score 60–70 242 (39.5)
70–100 370 (60.5)
Severity of CINV Grade 0 48 (7.8)
Grade I-II 291 (47.6)
Grade III-IV 273 (44.6)
TNM tumor-node-metastasis staging, KPS Karnofsky performance status,
CINV chemotherapy-induced nausea and vomiting
aHistory of nausea and vomiting was defined as any persistent event of
nausea and vomiting that affected their lives and/or required
medical interventions
Liu et al. BMC Complementary and Alternative Medicine  (2016) 16:451 Page 4 of 9
There were no differences in the severity of CINV between
the different constitution groups (P = 0.529).
Risk factors for severe CINV
Table 4 presents the univariate analysis of clinical charac-
teristics in relation to CINV severity. History of vomiting
was more frequent in the mild CINV group compared
with the severe CINV group (22.7 % vs. 13.6 %, P = 0.004).
TNM staging distribution was different between the two
groups (P = 0.03).
In univariate analyses, Yin-deficiency (P= 0.001), wetness-
heat (P = 0.012), and phlegm-wetness (P = 0.028) types were
associated with severe CINV (Table 4). Table 5 shows that a
history of vomiting was an independent protecting fac-
tor against severe CINV (OR = 0.548, 95 % CI: 0.353–
0.849, P = 0.007), while progesterone receptor positivity
(OR = 1.429, 95 % CI: 1.030–1.981, P = 0.032) and the
Table 2 Incidence of nausea and vomiting among breast cancer
patients after receiving different chemotherapy regimens (%)





CAF 59 36 (61.0) 23 (39.0)
CEF 107 59 (55.1) 48 (44.9)
TEC 57 29 (50.9) 28 (49.1)
TE 122 74 (60.7) 48 (39.3)
TAC 61 40 (65.6) 21 (34.4)
TA 51 24 (47.1) 27 (52.9)
AC 40 21 (52.5) 19 (47.5)
EC 115 56 (48.7) 59 (51.3)
Comparison between groups showed that the incidence of nausea and
vomiting between the different chemotherapy groups was not statistically
significant (chi-square test, P = 0.342)
CINV chemotherapy-induced nausea and vomiting, CAF cyclophosphamide,
adriamycin, fluorouracil, CEF cyclophosphamide, epirubicin, and fluorouracil,
AC adriamycin and cyclophosphamide, EC epirubicin and fluorouracil, TAC
docetaxel, adriamycin, and cyclophosphamide, TEC docetaxel, epirubicin, and
cyclophosphamide, TA pacilitaxel and adriamycin, TE docetaxel and epirubicin











Gentleness 77 37 (48.1) 40 (51.9)
Qi-deficiency 83 38 (45.8) 45 (54.2)
Yin-deficiency 58 27 (43.8) 21 (36.2)
Wetness-heat 22 8 (36.4) 14 (63.6)
Qi-depression 146 66 (45.2) 80 (54.8)
Yang-deficiency 66 32 (48.5) 34 (51.5)
Blood-stasis 34 18 (52.9) 16 (47.1)
Phlegm-wetness 20 10 (50) 10 (50)
Special diathesis 4 0 (0) 4 (100)
Comparison between groups showed that the incidence of nausea and
vomiting between the different TCM constitution groups was not statistically
significant (P = 0.529)
CINV chemotherapy-induced nausea and vomiting
Table 4 Univariate analysis of clinical characteristics and
constitution scores with severe CINV






Age 48.5 ± 10.1 48.5 ± 9.7 0.382
Education level Junior middle
school or above
147 (43.4 %) 103 (37.7 %) 0.164
Below junior
middle school
192 (56.6 %) 170 (62.3 %)
History of
breast cancer
Yes 119 (35.1 %) 87 (31.9 %) 0.400
No 220 (64.9 %) 186 (68.1 %)
History of
vomiting
Yes 77 (22.7 %) 37 (13.6 %) 0.004
No 262 (77.3 %) 236 (86.4 %)
KPS score 60–70 262 (77.3 %) 215 (78.7 %) 0.663
70–100 77 (22.7 %) 58 (21.3 %)
TNM staging I 62 (18.3 %) 73 (26.7 %) 0.030
II 199 (58.7 %) 132 (48.3 %)
III 58 (17.1 %) 46 (16.9 %)
IV 20 (5.9 %) 22 (8.1 %)
ER Positive 102 (30.1 %) 89 (32.6 %) 0.505
Negative 237 (69.9 %) 184 (57.4 %)
PR Positive 145 (42.8 %) 137 (50.2 %) 0.068
Negative 194 (57.2 %) 136 (49.8 %)
HER2 Negative 213 (62.8 %) 171 (62.6 %) 0.961
Positive 126 (37.2 %) 102 (37.4 %)
P21 Negative 259 (76.4 %) 199 (72.9 %) 0.320
Positive 80 (23.6 %) 74 (27.1 %)
P53 Negative 289 (85.3 %) 221 (81.0 %) 0.156
Positive 50 (14.7 %) 52 (19.0 %)
PCNA Negative 267 (78.8 %) 206 (75.5 %) 0.332
Positive 72 (21.2 %) 67 (24.5 %)
TCM
constitutions
Qi-deficiency 21.3 ± 13.8 22.7 ± 14.4 0.439
Yin-deficiency 20.3 ± 13.7 21.5 ± 11.5 0.001
Wetness-heat 14.6 ± 10.5 17.6 ± 12.5 0.012
Qi-depression 26.3 ± 16.2 29.4 ± 16.0 0.968
Yang-deficiency 18.8 ± 15.8 20.0 ± 16.4 0.341
Blood-stasis 19.3 ± 12.1 21.3 ± 12.4 0.453
Phlegm-wetness 17.3 ± 10.5 18.3 ± 11.5 0.028
Gentleness 69.0 ± 12.7 68.0 ± 13.7 0.275
TNM tumor node metastasis staging, KPS Karnofsky performance status,
CINV chemotherapy-induced nausea and vomiting, ER estrogen receptors,
PR progesterone receptor, HER2 human epidermal growth factor receptor 2,
PCNA proliferating cell nuclear antigen
Liu et al. BMC Complementary and Alternative Medicine  (2016) 16:451 Page 5 of 9
wetness-heat score (OR = 1.021, 95 % CI: 1.007–1.021,
P < 0.001) were risk factors for severe CINV.
Table 6 shows the univariate and multivariate analyses
of the items of the wetness heat constitution. Compared
with patients with mild CINV, patients with severe CINV
showed higher scores for greasy feeling/shining face or
nose (P < 0.001), prone to acne or furuncles (P = 0.004),
and sticky stool/sense of endless flow (P < 0.001). Bitter
taste/smelly mouth was an independent risk factor for se-
vere CINV (OR = 1.209, 95 % CI: 1.035–1.412, P = 0.017).
Discussion
Over the past 25 years, revolutionary progress has been
achieved in preventing CINV. It is now possible to avoid
CINV in most patients using the methods recommended
by the different available guidelines [2], but complete pre-
vention is still unachievable [23]. Therefore, a better under-
standing of the risk factors for CINV could help the
clinicians in the management of their patients. Therefore,
the aim of the present study was to investigate the risk
factors among TCM constitutions that are associated with
CINV among patients with primary breast cancer undergo-
ing chemotherapy. Results revealed that there was no
difference in the incidence of CINV among breast cancer
patients receiving different chemotherapy regimens, and
among patients with different TCM constitutions. The
wetness-heat constitution score was an independent risk
factor for severe CINV. In-depth analyses of the wetness-
heat constitution showed that bitter taste or smelly mouth
was a risk factor for severe CINV. Progesterone receptor
positivity was a risk factor for severe CINV. Vomiting
history was an independent protective factor against CINV.
In the present study, most patients with breast cancer had
a deviation in TCM constitution, mainly qi-depression, qi-
deficiency, yang-deficiency, and yin-deficiency constitutions,
among which the last three constitutions belong to weak-
ened body resistance [10]. Some studies revealed that breast
tumor size <2.0 cm was commonly seen in patients with qi-
depression and weakened body resistance [24], which
support the present study. Qi-depression is associated with
uncomfortable liver and often manifests clinical syndromes
such as depression, nervousness, and anxiety [10].
In the present study, CINV severity was classified as
mild (grade 0-II) or severe (grade III-IV). Although the
incidence of CINV was not different among patients
with different TCM constitutional types, multivariate
analyses showed that the wetness-heat constitution score
was an independent risk factor of CINV. According to
the theory of TCM, the formation of the wetness-heat
constitution is associated with wet climate or wet living
environment, but also with excessive alcohol, sweet or
greasy foods, and digestive disorders. Previous studies
have suggested that a history of alcohol intake is a risk
factor of CINV, suggesting that patients shall probably
reduce alcohol consumption, but also shall reduce the
intake of greasy and sweet foods during chemotherapy
[3]. In the present study, the incidence of CINV among
patients diagnosed with wetness-heat constitution was
slightly higher than in the other groups. Nevertheless, as
the score was an independent risk factor for severe
CINV, it could be considered that the risk of vomiting
was significantly increased in patients without meeting
all the items of the wetness-heat constitution. Therefore,
the components of the wetness-heat constitution were
further analyzed and the results showed that bitter taste/
smelly mouth was an independent risk factor for severe
Table 5 Multivariate analysis of risk factors for severe CINV
among breast cancer patients
P OR 95 % confidence interval
Lower limit Upper limit
History of vomiting 0.007 0.548 0.353 0.849
PR positivity 0.032 1.429 1.030 1.981
Wetness-heat score <0.001 1.012 1.007 1.021
TNM staging 0.550 1.063 0.870 1.300
Yin-deficiency score 0.376 0.993 0.977 1.009
Phlegm-wetness score 0.593 0.995 0.978 1.013
Logistic regression, forward conditional method
OR odds ratio, PR progesterone receptor
Table 6 Univariate and multivariate analyses of the six items of the wetness-heat constitution for severe CINV among breast cancer patients





P OR 95 % confidence interval P
Lower limit Upper limit
Greasy feeling or shinning face or nose 1.50 ± 0.82 1.67 ± 1.03 <0.001 1.154 0.965 1.381 0.117
Prone to acne or furuncle 1.19 ± 0.52 1.26 ± 0.63 0.004 1.182 0.887 1.574 0.253
Bitter taste or smelly mouth 1.80 ± 1.02 2.05 ± 1.11 0.056 1.209 1.035 1.412 0.017
Sticky stool and sense of endless flow 1.42 ± 0.75 1.56 ± 0.89 <0.001 1.147 0.936 1.405 0.186
Hot flash in urethra and dark urine 1.54 ± 0.77 1.59 ± 0.86 0.051 1.041 0.848 1.277 0.703
Yellow leukorrhea 1.62 ± 0.96 1.68 ± 0.96 0.260 – – – –
Multivariate analysis was performed through logistic regression, forward conditional method
OR odds ratio
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CINV. The use of CINV prophylaxis might more pertin-
ent in these patients.
Previous studies revealed that some clinical characteris-
tics are risk factors for CINV such as history of hyperem-
esis gravidarum, history of nausea/vomiting, anxiety,
expectation of nausea, young age, and tumor-related
fatigue [7–9]. At the participating hospitals, chemotherapy
regimens with a high emetogenic potential are often used,
and anti-emesis prophylaxis is rarely used because of
patients’ financial limitations. Therefore, only 48 patients
did not suffer from CINV, preventing the assessment of
whether a history of nausea/vomiting was a risk factor of
CINV. However, compared with patients without a history
of nausea/vomiting, a larger proportion of patients with a
history of nausea/vomiting had mild CINV. A previous
study found that a history of vomiting could be considered
as a risk factor of CINV during the 2nd cycle of chemo-
therapy, but not during the 3rd cycle of chemotherapy [8],
suggesting that a history of nausea/vomiting is only of sig-
nificance at a specific stage of the chemotherapy process.
Therefore, in-depth studies are needed to clarify whether
a history of nausea/vomiting is a risk factor of CINV.
The present study suggests that patients with PR-
positive breast cancer had a higher probability of severe
CINV than patients with PR-negative cancer. However,
further study is necessary to assess this point. Age was not
found to be a risk factor of CINV, which might be because
most patients (88.9 %) were 35–60 years old. In addition,
according to the TCM, qi-depression is associated with
anxiety [10]. However, qi-depression was not found to be
a risk factor of CINV in this study. Since TCM constitu-
tions are a group of symptoms, considering TCM consti-
tutions as risk factors may lead to the omission of some
useful clinical information. Thus, in subsequent research,
the 60 items of the Constitution in Chinese Medicine
Questionnaire should be separately considered as risk
factors. In addition, patients with the special diathesis
constitution were excluded from the analyses because of
the very small number of cases (n = 4). Nevertheless, it is
worth noting that all four cases with special diathesis suf-
fered from severe CINV. According to TCM, the special
diathesis constitution is a kind of allergic constitution and
it might be possible that this constitution is associated
with an adverse reaction to chemotherapy [10].
The present study is not without limitations. Indeed,
even if the sample size was large, some subgroups were
too small for statistical analysis; and analyses according to
the chemotherapy regimens were not possible. In addition,
the variety of chemotherapy regimens might have influ-
enced the results since their emetogenic potentials were
different. Finally, there could be some bias since hospital-
ized patients filled the paper form of the FLIE under
assistance of medical staff, if needed, while patients at
home responded to the FLIE by phone.
Conclusions
TCM constitutional types are unable to predict the
occurrence of severe CINV, while higher wetness-heat
score, especially with bitter taste/smelly mouth, is a risk
factor of severe CINV. PR positivity was also a risk
factor for severe CINV, while a history of vomiting was a
protection factor against severe CINV.
Appendix






1. Are you full of energy? 1,2,3,4,5
2. Do you easily tired? 1,2,3,4,5
3. Are you susceptible to shortness of breath? 1,2,3,4,5
4. Are you susceptible to (fast heartbeat)? 1,2,3,4,5
5. Are you susceptible to feel dizzy? Or when you
stand up, you feel dizzy? 1,2,3,4,5
6. Would you like to be quiet and lazy to talk? 1,2,3,4,5
7. Do you have a low voice? 1,2,3,4,5
8. Are you easy to forget things? 1,2,3,4,5
9. Do you feel bored and depressed? 1,2,3,4,5
10. Are you nervous and anxious? 1,2,3,4,5
11. Do you always feel melancholy? 1,2,3,4,5
12. Are you susceptible to feel scared or frightened?
1,2,3,4,5
13. Do you feel chest pain? 1,2,3,4,5
14. Do you feel chest tightness (especially in rainy and
humid weather)? 1,2,3,4,5
15. Are you susceptible to sigh without special reason?
1,2,3,4,5
16. Do you feel your body too heavy to move? 1,2,3,4,5
17. Do you feel your hands and feet are hot? 1,2,3,4,5
18. Do you feel your hands and feet are cold? 1,2,3,4,5
19. Do you feel a cold waist ? 1,2,3,4,5
20. Do you feel cold, and wear more than others?
1,2,3,4,5
21. Do you feel the hot of your body and face? 1,2,3,4,5
22. Do you feel that you can't tolerate the cold in the
winter than others? 1,2,3,4,5
23. Do you feel that you are more susceptible to catch
a cold than others? 1,2,3,4,5
24. Do you sneeze even though you do not have a
cold? 1,2,3,4,5
25. Do you often have a runny nose, even if it is not a
cold? 1,2,3,4,5
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26. Do you often have a stuffy nose, even if you are
not a cold 1,2,3,4,5
27. Do you feel that though slightly active or inactive,
you are easy to sweat (spontaneous)? 1,2,3,4,5
28. Do you have a sticky sweat ? 1,2,3,4,5
29. Do you find you have feet wet? 1,2,3,4,5
30. Are you easy to be allergies (drugs, food, smell,
pollen)? 1,2,3,4,5
31. Is your skin easy to onset hives (urticaria and
urticaria)? 1,2,3,4,5
32. Is your skin allergy to appeared purpura (purple
petechia) 1,2,3,4,5?
33. Is your skin often appear black imperceptibly
bleeding spots (subcutaneous hemorrhage)? 1,2,3,4,5
34. Is your skin susceptible to turn red and scratches
after scratch? 1,2,3,4,5
35. Is your skin dryness? 1,2,3,4,5
36. Is your skin rough and delicate? 1,2,3,4,5
37. Do you feel pain here and there? 1,2,3,4,5
38. Is your face usually flushing or partial red? 1,2,3,4,5
39. Is your face or nose oily or greasy? 1,2,3,4,5
40. Is your complexion dullness? 1,2,3,4,5
41. Are you prone to acne? 1,2,3,4,5
42. Do you have a swollen eyes (the lower eyelids)?
1,2,3,4,5
43. have a dark circles around the eyes.? 1,2,3,4,5
44. Do you feel dryness of eyes? 1,2,3,4,5
45. Do you have eye congestion (redness) ? 1,2,3,4,5
46. Do you feel dry mouth and throat? 1,2,3,4,5
47. Do you have a feeling of blockage in the throat?
1,2,3,4,5
48. Do you feel a bitter taste in the mouth? 1,2,3,4,5
49. Do you have a sticky feeling in your mouth?
1,2,3,4,5
50. Do you sleep easily? 1,2,3,4,5
51. Do you have phlegm? 1,2,3,4,5
52. Do you feel uncomfortable after eating or drinking
cool things? Or you donnot like to have cold
things? 1,2,3,4,5
53. Do you sleep well 1,2,3,4,5
54. Do you easily sleep? 1,2,3,4,5
55. Are you susceptible to have loose stool? 1,2,3,4,5
56. Do you have a sticky stool? 1,2,3,4,5
57. Do you have a dry stool or constipation, 1,2,3,4,5
58. Do you have a lot of urine, or a frequent
micturition? 1,2,3,4,5
59. Do you have a sense of fever in the urethra? Is
your urine’s color darkness? 1,2,3,4,5
60. Do you have decadent leucorrhea? 1,2,3,4,5
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